During the past decade, Focal Point Vision conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Focal Point Vision" #1 sponsor was "Johnson & Johnson Surgical Vision, Inc." with 5 trials, followed by "Abbott Medical Optics" with 2 trials sponsored, "Glaukos Corporation" with 2 trials sponsored, "RxSight, Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Focal Point Vision" #1 collaborator was "Jaeb Center for Health Research" with 1 trials as a collaborator and "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Focal Point Vision" are "Cataract" (8 trials), "Aphakia" (3 trials), "Cataracts" (2 trials), "Corneal Astigmatism" (2 trials) and "Keratoconus" (2 trials). Many other conditions were trialed in "Focal Point Vision" in a lesser frequency.

Most popular intervention types in "Focal Point Vision" are "Device" (14 trials), "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control IOL" (2 trials), "Light Adjustable lens (LAL) and Light Delivery Device (LDD)" (2 trials), "Active Comparator: Timolol 0.5%" (1 trials), "Artisan Aphakia Intraocular Lens" (1 trials) and "Bimatoprost SR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Focal Point Vision" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Focal Point Vision". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Focal Point Vision, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Focal Point Vision, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".